<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57189</article-id><article-id pub-id-type="doi">10.7554/eLife.57189</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to Oesophageal Adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-181333"><name><surname>Rogerson</surname><given-names>Connor</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1425-9668</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181335"><name><surname>Ogden</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181332"><name><surname>Britton</surname><given-names>Edward</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>the OCCAMS consortium</collab></contrib><contrib contrib-type="author" corresp="yes" id="author-118911"><name><surname>Ang</surname><given-names>Yeng</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0496-6710</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-31508"><name><surname>Sharrocks</surname><given-names>Andrew D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7395-9552</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Hutchison/MRC Research Centre</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Faculty of Biology, Medicine and Health</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">School of Medical Sciences, Faculty of Biology, Medicine and Health</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-14864"><name><surname>Davidson</surname><given-names>Irwin</given-names></name><role>Reviewing editor</role><aff><institution>Institut de Génétique et de Biologie Moléculaire et Cellulaire</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Yeng.Ang@srft.nhs.uk</email> (YA);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>andrew.d.sharrocks@manchester.ac.uk</email> (AS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>09</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e57189</elocation-id><history><date date-type="received"><day>24</day><month>03</month><year>2020</year></date><date date-type="accepted"><day>03</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Rogerson et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Rogerson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57189-v1.pdf"/><abstract><p>Oesophageal adenocarcinoma (OAC) is one of the most common causes of cancer deaths. Barrett's oesophagus (BO) is the only known precancerous precursor to OAC, but our understanding about the molecular events leading to OAC development is limited. Here, we have integrated gene expression and chromatin accessibility profiles of human biopsies and identified a strong cell cycle gene expression signature in OAC compared to BO. Through analysing associated chromatin accessibility changes, we have implicated the transcription factor KLF5 in the transition from BO to OAC. Importantly, we show that KLF5 expression is unchanged during this transition, but instead, KLF5 is redistributed across chromatin to directly regulate cell cycle genes specifically in OAC cells. This new KLF5 target gene programme has potential prognostic significance as high levels correlate with poorer patient survival. Thus, the repurposing of KLF5 for novel regulatory activity in OAC provides new insights into the mechanisms behind disease progression.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>Clinical PhD and PhD funding</award-id><principal-award-recipient><name><surname>Rogerson</surname><given-names>Connor</given-names></name><name><surname>Britton</surname><given-names>Edward</given-names></name><name><surname>Ang</surname><given-names>Yeng</given-names></name><name><surname>Sharrocks</surname><given-names>Andrew D</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>Programme grant and studentship103857/Z/14/Z</award-id><principal-award-recipient><name><surname>Ogden</surname><given-names>Samuel</given-names></name><name><surname>Sharrocks</surname><given-names>Andrew D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval was via the ethics committee of Salford Royal NHS Foundation Trust (04/Q1410/57). Patient consent was obtained in written form and signed by the patient and doctor.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All sequencing data are deposited in ArrayExpress. Additional OAC ATAC-seq data are available at E-MTAB-8447 and additional BO and OAC RNA-seq data are available at E-MTAB-8584. siKLF5 RNA-seq data are available at E-MTAB-8446. KLF5 ChIP-seq data are available at E-MTAB-8568. siERBB2 ATAC-seq and RNA-seq data are available at E-MTAB-8576 and E-MTAB-8579 respectively.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8447">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8447</ext-link><comment>ArrayExpress, E-MTAB-8447</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8446">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8446</ext-link><comment>ArrayExpress, E-MTAB-8446</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8568">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8568</ext-link><comment>ArrayExpress, E-MTAB-8568</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8584">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8584</ext-link><comment>ArrayExpress, E-MTAB-8584</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8576">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8576</ext-link><comment>ArrayExpress, E-MTAB-8576</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8579">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8579</ext-link><comment>ArrayExpress, E-MTAB-8579</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/datasets/EGAD00001005915">https://ega-archive.org/datasets/EGAD00001005915</ext-link><comment>EGA, EGAD00001005915</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Ogden S</collab><collab>Britton E</collab><collab>the OCCAMs consortium</collab><collab>Yeng A</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2020">2020</year><source>Repurposing of KLF5 activates a cell cycle signature during the progression to Oesophageal Adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8994">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8994</ext-link><comment>ArrayExoress, E-MTAB-8994</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Britton E</collab><collab>Rogerson C</collab><collab>Mehta S</collab><collab>Li Y</collab><collab>Li X</collab><collab>the OCCAMS consortium</collab><collab>Fitzgerald RC</collab><collab>Ang YS</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2017">2017</year><source>Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5169">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5169</ext-link><comment>ArrayExpress, E-MTAB-5169</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Britton E</collab><collab>Withey S</collab><collab>Hanley N</collab><collab>Ang Y</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2019">2019</year><source>Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its pre-cancerous precursor state</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6751">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6751</ext-link><comment>ArrayExpress, E-MTAB-6751</comment></element-citation><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Britton E</collab><collab>Withey S</collab><collab>Hanley N</collab><collab>Ang Y</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2019">2019</year><source>Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its pre-cancerous precursor state</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6756">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6756</ext-link><comment>ArrayExpress, E-MTAB-6756</comment></element-citation><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Rogerson C</collab><collab>Britton E</collab><collab>Withey S</collab><collab>Hanley N</collab><collab>Ang Y</collab><collab>Sharrocks AD</collab></person-group><year iso-8601-date="2019">2019</year><source>Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its pre-cancerous precursor state</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6858">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6858</ext-link><comment>ArrayExpress, E-MTAB-6758</comment></element-citation><element-citation id="dataset13" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Maag JLV</collab><collab>Fisher OM</collab><collab>Levert-Mignon A</collab><collab>Kaczorowski DC</collab><collab>Thomas ML</collab><collab>Hussey DJ</collab><collab>Watson DI</collab><collab>Wettstein A</collab><collab>Bobryshev YV</collab><collab>Edwards M</collab><collab>Dinger ME</collab><collab>Lord RV</collab></person-group><year iso-8601-date="2017">2017</year><source>Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4054">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4054</ext-link><comment>ArrayExpress, E-MTAB-4054</comment></element-citation><element-citation id="dataset14" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Corces MR</collab><collab>Granja JM</collab><collab>Shams S</collab><collab>Louie BH</collab><collab>Seoane</collab><collab>JA</collab><collab>Zhou W</collab><collab>Silva TC</collab><collab>Groeneveld C</collab><collab>Wong CK</collab><collab>Cho SW</collab><collab>Satpathy AT</collab><collab>Mumbach MR</collab><collab>Hoadley KA</collab><collab>Robertson AG</collab><collab>Sheffield NC</collab><collab>Felau I</collab><collab>Castro MAA</collab><collab>Berman BP</collab><collab>Staudt LM</collab><collab>Zenklusen JC</collab><collab>Laird PW</collab><collab>Curtis C</collab><collab>TCGA Network</collab><collab>Greenleaf WJ</collab><collab>Chang HY</collab></person-group><year iso-8601-date="2018">2018</year><source>The chromatin accessibility landscape of primary human cancers</source><ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/projects/TCGA-ESCA">https://portal.gdc.can- cer.gov/projects/TCGA- ESCA</ext-link><comment>GDC Data Portal, TCGA-ESCA</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57189-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>